跳至主要内容
临床试验/IRCT20190905044703N1
IRCT20190905044703N1招募中3 期

Effect of buprenorphine on the treatment of psychosis in bipolar patients with psychotic symptoms

Kerman University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age 18 to 65
  • Diagnosis of type 1 BMD (Depression episode, Mania with Psychotic Leader) (based on DSM-V criteria)
  • Initial Severity of Positive Symptoms: BPRS psychotic score with a score of 12 or greater and at least two BPRS psychotic items with a score of 4 or more

排除标准

  • A history of methamphetamine use within the last 3 months
  • Alcohol dependence or benzodiazepines or hallucinogenic substances
  • Diagnosis of methamphetamine-induced sustained psychosis

研究者

相似试验